Asia Pacific Endoscopy Procedures Market Forecast to 2030 - Regional Analysis -By Procedures [Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Submucosal Dissection (ESD), Peroral Endoscopic Myotomy (POEM), Endoscopic Ultrasound (EUS), In

Asia Pacific Endoscopy Procedures Market Forecast to 2030 - Regional Analysis -By Procedures [Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Submucosal Dissection (ESD), Peroral Endoscopic Myotomy (POEM), Endoscopic Ultrasound (EUS), Interventional Pulmonology and Laparoscopy, Arthroscopy and Bronchoscopy, Colonoscopy and Colposcopy, Proctoscopy and Thoracoscopy, and Others], Offering [Endoscopes, ERCP Accessories, Head positioner and Endotherapy Injection Needles, Sampling Device and Device Clip and Electrosurgical Knife, Endoscopic Ultrasound (EUS) Guided Devices, Guidewire, Forceps, Snare, Irrigation/Insufflation tubing systems, Probes, Hemostasis Clip, Polyp Traps, Single-Use Valves , Trocar sleeves and Tissue Scissors and Cutters, Retrieval Devices, and Others (Kits/Stents/Energy Devices/ Transport pad/Cleaning Brush/OT Lights, etc.)], Product Type (Disposable and Reusable), and End User (Hospitals and Clinics, Ambulatory Surgical Centres, Diagnostic Laboratories, and Others)

The Asia Pacific endoscopy procedures market is expected to grow from US$ 8,044.94 million in 2022 to US$ 14,103.00 million by 2030. It is estimated to grow at a CAGR of 7.3% from 2022 to 2030.

Increasing Prevalence of Cancer Fuel to the Asia Pacific Endoscopy Procedures Market

Cancer is a major public health problem and leading cause of death across the world. Increasing gastrointestinal disorders and cancer cases also accelerate the endoscope adoption and market growth. Colorectal cancer is increasingly affecting populations in Asian countries. According to the International Agency for Research on Cancer & GLOBOCON, ~1 million new colorectal cancer cases were reported in Asia in 2020. Japan, China, Malaysia, Singapore, and South Korea witnessed high prevalence rates compared to other countries in the region. Additionally, Asia had the highest global percentages of incident (51.8%) and death (52.4%) colorectal cancer cases (all age groups and genders) per 100,000 people in 2018. Furthermore, this disease has been increasingly prevalent throughout Asia, with certain regional and geographic variations. Westernized food, an aging population, smoking, physical inactivity, and other risk factors are the major causes of this increase in CRC. Furthermore, the most recent estimates from GLOBOCAN for 2020 show that only 60% (1,315,136) of newly diagnosed cases of lung cancer and 62% (1,112,517) of all lung cancer-related fatalities occurred in Asia. Also, gastric cancer (GC) is considered one of the most dangerous cancers in the world; in 2020, there were over one billion new cases and 783,000 deaths from GC. Asian nations have a notably high incidence of GC, and Eastern Asia has recently recorded more than 60% of GC cases. Compared to populations in Western nations, stomach cancer has historically impacted East Asian populations disproportionately. In Japan, stomach cancer is the most frequent cancer among men, and half of all occurrences of the disease occur in China. Inflammatory bowel disease (IBD) is a term for two conditions – ulcerative colitis (UC) and Crohn’s disease (CD). Moreover, in the last few years, cases of IBD have increased worldwide due to a sedentary lifestyle, changing dietary habits, stress, and poor nutritional choices. The intake of processed foods and trans-fats has drastically increased globally. Also, Asia saw a rise in IBD cases from 763,544 in 1990 to 1,992,221.5 in 2019. Asia had the highest overall incidence and prevalence of IBD among the four continents in 2019. Also, according to the IBS Global Impact Report, in 2016, the estimated prevalence of irritable bowel syndrome in Asia was 9.6%. Further, chronic inflammation and reduced immunosurveillance caused by IBD may contribute to the development of gastric cancer. Thus, the rising burden of cancer in the region indicates the high requirement for endoscopic devices, thus driving the market growth.

Asia Pacific Endoscopy Procedures Market Overview

The endoscopic procedures market in Asia Pacific is segmented into India, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. This region accounted for over 26.05% of the global endoscopy procedure market owing to a large population base in countries such as China and India. The increasing focus of market players on introducing new products or therapies is the major factor promoting the market growth.

Asia Pacific Endoscopy Procedures Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Endoscopy Procedures Market Segmentation

The Asia Pacific endoscopy procedures market is segmented into procedure, offering, product type, and end user.

Based on procedure, the Asia Pacific endoscopy procedures market is segmented into endoscopic retrograde cholangiopancreatography (ERCP), endoscopic submucosal dissection (ESD), peroral endoscopic myotomy (POEM), endoscopic ultrasound (EUS), interventional pulmonology and laparoscopy, arthroscopy and bronchoscopy, colonoscopy and colposcopy, proctoscopy and thoracoscopy, and others. The arthroscopy and bronchoscopy segment held the largest share of the Asia Pacific endoscopy procedures market in 2022.

Based on offering, the Asia Pacific endoscopy procedures market is segmented endoscopes, ERCP accessories, visualization system, head positioner and endotherapy injection needles, sampling device and device clip and electrosurgical knife, endoscopic ultrasound guided devices, guidewire, forceps, snare, irrigation/insufflation tubing systems, probes, hemostats clip, polyps’ traps, single-use valves, trocar sleeves and tissue scissors and cutters, retrieval devices, and Others (Kits/Stents/Energy Devices/ Transport pad/Cleaning Brush/OT Lights etc.). The endoscopes segment held the largest share of the Asia Pacific endoscopy procedures market in 2022.

Based on product type, the Asia Pacific endoscopy procedures market is bifurcated into disposable and reusable. The reusable segment held a larger share of the Asia Pacific endoscopy procedures market in 2022.

Based on end user, the Asia Pacific endoscopy procedures market is segmented into hospitals and clinics, ambulatory surgical centres, diagnostic laboratories, and others. The hospitals and clinics segment held the largest share of the Asia Pacific endoscopy procedures market in 2022.

Based on country, the Asia Pacific endoscopy procedures market is segmented int o the India, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific endoscopy procedures market in 2022.

Stryker Corp, FUJIFILM Holdings Corp, Merit Medical Systems Inc, Smith & Nephew Plc, Arthrex Inc, Steris Plc, Conmed Corp, Olympus Corp, Boston Scientific Corp, and Cook Medical LLC, are some of the leading companies operating in the Asia Pacific endoscopy procedures market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific endoscopy procedures market.
Highlights key business priorities to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific endoscopy procedures market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.